Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Genuine Parts Company (GPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Genuine Parts Company — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.47 (market cap $30.93B), while Genuine Parts Company trades at $132.81 (market cap $18.15B). The key difference: GE HealthCare Technologies Inc. Common Stock is the larger of the two by market cap, and Genuine Parts Company pays the higher dividend (3.23%). Which is the better fit depends on your goals.
| GEHC | GPC | |
|---|---|---|
Market Cap | $30.93B | $18.15B |
Volume | 5,033,451 | 829,167 |
Sector | Health | Consumer Cyclical |
52-Week High | $88.16 | $149.26 |
52-Week Low | $59.48 | $92.47 |
Enterprise Value | $39.39B | $24.24B |
Dividend Yield | 0.23% | 3.23% |
Typical Hold Time | — | 75 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
GPC trades at $130.71, up 0.84% today, with a bullish technical signal and support near $127. The company reported mixed quarterly earnings, beating in Q1 and Q2 but missing in Q4 2025, while revenue grew to $24.3B in 2025. Net income margin remains thin at 0.13%, and the P/E ratio is elevated at 522.84, indicating high earnings expectations. Recent news highlights the planned spinoff of its industrial unit, Motion, by Q1 2027, which could unlock value.
The outlook is cautiously optimistic, driven by the corporate split catalyst and steady dividend yield, but risks include compressed profitability, high debt levels, and economic sensitivity. Analysts maintain a buy consensus with a $145.75 price target, suggesting 11.5% upside, though execution on the separation and margin improvement are critical for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →
